These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34218423)

  • 1. A De Novo SEMA6B Variant in a Chinese Patient with Progressive Myoclonic Epilepsy-11 and Review of the Literature.
    Li Q; Liu M; Huang DP; Li T; Huang J; Jiang P; Ling WH; Chen XQ
    J Mol Neurosci; 2021 Sep; 71(9):1944-1950. PubMed ID: 34218423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De Novo Truncating Variants in the Last Exon of SEMA6B Cause Progressive Myoclonic Epilepsy.
    Hamanaka K; Imagawa E; Koshimizu E; Miyatake S; Tohyama J; Yamagata T; Miyauchi A; Ekhilevitch N; Nakamura F; Kawashima T; Goshima Y; Mohamed AR; Ch'ng GS; Fujita A; Azuma Y; Yasuda K; Imamura S; Nakashima M; Saitsu H; Mitsuhashi S; Mizuguchi T; Takata A; Miyake N; Matsumoto N
    Am J Hum Genet; 2020 Apr; 106(4):549-558. PubMed ID: 32169168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zonisamide-responsive myoclonus in SEMA6B-associated progressive myoclonic epilepsy.
    Herzog R; Hellenbroich Y; Brüggemann N; Lohmann K; Grimmel M; Haack TB; von Spiczak S; Münchau A
    Ann Clin Transl Neurol; 2021 Jul; 8(7):1524-1527. PubMed ID: 34092044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive myoclonus epilepsies due to SEMA6B mutations. New variants and appraisal of published phenotypes.
    Castellotti B; Canafoglia L; Freri E; Tappatà M; Messina G; Magri S; DiFrancesco JC; Fanella M; Di Bonaventura C; Morano A; Granata T; Gellera C; Franceschetti S; Michelucci R
    Epilepsia Open; 2023 Jun; 8(2):645-650. PubMed ID: 36719163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-convulsive Status Epilepticus in
    Duan J; Chen Y; Hu Z; Ye Y; Zhang T; Li C; Zeng Q; Zhao X; Mai J; Sun Y; Liu C; Zheng W; Xiao Y; Liao J; Chen L
    Front Pediatr; 2022; 10():859183. PubMed ID: 35573939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenic gene variants and clinical phenotype features of 26 children with progressive myoclonic epilepsy].
    Zhang J; Zhang YH; Chen JY; Ji TY; Yang ZX; Yang XL; Sun W; Zhang LP; Wu XR
    Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):458-464. PubMed ID: 31216804
    [No Abstract]   [Full Text] [Related]  

  • 7. Whole exome sequencing identifies variable expressivity of CLN6 variants in Progressive myoclonic epilepsy affected families.
    Ilyas M; Tariq F; Ishaq R; Habiba U; Bibi F; Khan SN; Ali Y; Haider S; Efthymiou S; Abdullah U; Raja GK; Shaiq PA
    Epilepsy Res; 2024 Mar; 201():107283. PubMed ID: 38382230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Truncating and Missense Variants in
    Xiaozhen S; Fan Y; Fang Y; Xiaoping L; Jia J; Wuhen X; Xiaojun T; Jun S; Yucai C; Hong Z; Guang H; Shengnan W
    Front Cell Dev Biol; 2021; 9():633819. PubMed ID: 34017830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel
    Chen Y; Yang X; Yan X; Shen L; Guo J; Xu Q
    Front Genet; 2023; 14():1110310. PubMed ID: 36873942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KCTD7-related progressive myoclonic epilepsy: report of three Indian families and review of literature.
    Narayanan DL; Somashekar PH; Majethia P; Shukla A
    Clin Dysmorphol; 2022 Jan; 31(1):6-10. PubMed ID: 34866617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SEMA6B variants cause intellectual disability and alter dendritic spine density and axon guidance.
    Cordovado A; Schaettin M; Jeanne M; Panasenkava V; Denommé-Pichon AS; Keren B; Mignot C; Doco-Fenzy M; Rodan L; Ramsey K; Narayanan V; Jones JR; Prijoles EJ; Mitchell WG; Ozmore JR; Juliette K; Torti E; Normand EA; Granger L; Petersen AK; Au MG; Matheny JP; Phornphutkul C; Chambers MK; Fernández-Ramos JA; López-Laso E; Kruer MC; Bakhtiari S; Zollino M; Morleo M; Marangi G; Mei D; Pisano T; Guerrini R; Louie RJ; Childers A; Everman DB; Isidor B; Audebert-Bellanger S; Odent S; Bonneau D; Gilbert-Dussardier B; Redon R; Bézieau S; Laumonnier F; Stoeckli ET; Toutain A; Vuillaume ML
    Hum Mol Genet; 2022 Sep; 31(19):3325-3340. PubMed ID: 35604360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SERPINI1 pathogenic variants: An emerging cause of childhood-onset progressive myoclonic epilepsy.
    Ranza E; Garcia-Tarodo S; Varvagiannis K; Guipponi M; Lobrinus JA; Bottani A; Kern I; Kurian M; Pittet MP; Antonarakis SE; Fluss J; Korff CM
    Am J Med Genet A; 2017 Sep; 173(9):2456-2460. PubMed ID: 28631894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive myoclonus epilepsies-Residual unsolved cases have marked genetic heterogeneity including dolichol-dependent protein glycosylation pathway genes.
    Courage C; Oliver KL; Park EJ; Cameron JM; Grabińska KA; Muona M; Canafoglia L; Gambardella A; Said E; Afawi Z; Baykan B; Brandt C; di Bonaventura C; Chew HB; Criscuolo C; Dibbens LM; Castellotti B; Riguzzi P; Labate A; Filla A; Giallonardo AT; Berecki G; Jackson CB; Joensuu T; Damiano JA; Kivity S; Korczyn A; Palotie A; Striano P; Uccellini D; Giuliano L; Andermann E; Scheffer IE; Michelucci R; Bahlo M; Franceschetti S; Sessa WC; Berkovic SF; Lehesjoki AE
    Am J Hum Genet; 2021 Apr; 108(4):722-738. PubMed ID: 33798445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome sequencing identifies compound heterozygous KCTD7 mutations in a girl with progressivemyoclonus epilepsy.
    Mei L; Huang Y; Chen J; He X; Lin S; Liao L; Wang X; Huang X; Sha Y; Ji Z; Li P
    Clin Chim Acta; 2019 Jun; 493():87-91. PubMed ID: 30825425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel homozygous splice-site mutation in SCARB2 is associated with progressive myoclonic epilepsy with renal failure.
    Yari A; Ali-Nejad RM; Saleh-Gohari N
    Neurol Sci; 2021 Dec; 42(12):5077-5085. PubMed ID: 33772352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive myoclonic epilepsy as an expanding phenotype of NGLY1-associated congenital deglycosylation disorder: A case report and review of the literature.
    Sonoda Y; Fujita A; Torio M; Mukaino T; Sakata A; Matsukura M; Yonemoto K; Hatae K; Ichimiya Y; Chong PF; Ochiai M; Wada Y; Kadoya M; Okamoto N; Murakami Y; Suzuki T; Isobe N; Shigeto H; Matsumoto N; Sakai Y; Ohga S
    Eur J Med Genet; 2024 Feb; 67():104895. PubMed ID: 38070824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive myoclonus epilepsy without renal failure in a Chinese family with a novel mutation in SCARB2 gene and literature review.
    Tian WT; Liu XL; Xu YQ; Huang XJ; Zhou HY; Wang Y; Tang HD; Chen SD; Luan XH; Cao L
    Seizure; 2018 Apr; 57():80-86. PubMed ID: 29605618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel NUS1 variant in a Chinese patient with progressive myoclonus epilepsy: a case report and systematic review.
    Ji C; Zhao J; Zhang J; Wang K
    Neurol Sci; 2023 Oct; 44(10):3495-3498. PubMed ID: 37249665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial cases of progressive myoclonic epilepsy caused by maternal somatic mosaicism of a recurrent KCNC1 p.Arg320His mutation.
    Kim H; Lee S; Choi M; Kim H; Hwang H; Choi J; Chae JH; Kim KJ; Lim BC
    Brain Dev; 2018 May; 40(5):429-432. PubMed ID: 29428275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IRF2BPL: A new genotype for progressive myoclonus epilepsies.
    Costa C; Oliver KL; Calvello C; Cameron JM; Imperatore V; Tonelli L; Colavito D; Franceschetti S; Canafoglia L; Berkovic SF; Prontera P
    Epilepsia; 2023 Aug; 64(8):e164-e169. PubMed ID: 36810721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.